MedPath

PRETERM DELİVERY and MYOCINE BINDING PROTEIN C LEVELs

Completed
Conditions
Preterm
Registration Number
NCT05513768
Lead Sponsor
Gaziosmanpasa Research and Education Hospital
Brief Summary

IT WAS AIMED TO EVALUATE IF MBPC CAN BE USED IN PREDICTION OF EARLY BIRTH. TAKING THE FIRST TRIMESTER FROM PREGNANCY WAS STORED UNTIL THE TIMING OF DELIVERY.THE PARTICIPANTS WERE SEPARATED INTO TWO GROUPS ACCORDING TO THE TIME OF BIRTH, EARLY AND TIMELY.

SERUM MBPC LEVELS BETWEEN TWO GROUPS EVALUATED.

Detailed Description

IT WAS AIMED TO EVALUATE IF MBPC CAN BE USED IN PREDICTION OF EARLY BIRTH. TAKING THE FIRST TRIMESTER FROM PREGNANCY WAS STORED UNTIL THE TIMING OF DELIVERY.THE PARTICIPANTS WERE SEPARATED INTO TWO GROUPS ACCORDING TO THE TIME OF BIRTH, EARLY AND TIMELY.

SERUM MBPC LEVELS BETWEEN TWO GROUPS EVALUATED.A TOTAL OF 90 WOMEN WERE PLANNED TO INCLUDE 45 STUDY 45 CONTROL GROUP IN THE STUDY.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • being pregnant in the first trimester
  • be between 18-40 years old
Exclusion Criteria
  • no history of preterm birth
  • being pregnant with assisted reproductive techniques
  • having a multiple pregnancy
  • have cervical insufficiency

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
detection of prediction value of serum mbpc levels in preterm delivery10 mounths

identifying prediction value of first trmester serum mbpc levels by comparing by serum levels of mbpc in groups

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gaziosmanpasa Training and Research Hospital

🇹🇷

Istanbul, Gaziosmanpaşa, Turkey

Gaziosmanpasa Training and Research Hospital
🇹🇷Istanbul, Gaziosmanpaşa, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.